Micro Interventional Devices, Inc. has completed enrollment in its Secure Transapical Access and Closure Study (STASIS). STASIS is a CE-Mark study that evaluates the safety and performance of the company’s Permaseal™, the world’s first automated direct myocardial ventricular access and closure technology especially designed for use in certain heart procedures. Read more: http://prn.to/1IkMdZZ
Client & Alumni News
Micro Interventional Devices Completes STASIS Clinical Trial Enrollment
The Ben Franklin Technology Partners is an initiative of the Pennsylvania Department of Community and Economic Development and is funded by the Ben Franklin Technology Development Authority.